ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phenprocoumon Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-36I8181
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Phenprocoumon Market Insights Forecast to 2028
BUY CHAPTERS

Global Phenprocoumon Market Research Report 2025

Code: QYRE-Auto-36I8181
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Mylan NV
TEVA
Roche
Aspen Pharmacare
Acis Arzneimittel
Wörwag Pharma

Phenprocoumon Market

The global market for Phenprocoumon was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Phenprocoumon (marketed under the brand names Marcoumar, Marcumar and Falithrom) is a long-acting oral anticoagulant drug, a derivative of coumarin. It is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).
North American market for Phenprocoumon is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Phenprocoumon is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Phenprocoumon include Novartis, Mylan, Teva, Roche, Aspen Pharmacare, Acis Arzneimittel, Wörwag Pharma, Divis Labs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Phenprocoumon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenprocoumon.
The Phenprocoumon market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Phenprocoumon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phenprocoumon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Phenprocoumon Market Report

Report Metric Details
Report Name Phenprocoumon Market
Segment by Type
  • 5 mg
  • 10 mg
  • 25 mg
  • 50 mg
Segment by Application
  • Venous Thrombosis
  • Thromboembolism
  • Pulmonary Embolism
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Mylan, Teva, Roche, Aspen Pharmacare, Acis Arzneimittel, Wörwag Pharma, Divis Labs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Phenprocoumon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Phenprocoumon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Phenprocoumon Market report?

Ans: The main players in the Phenprocoumon Market are Novartis, Mylan, Teva, Roche, Aspen Pharmacare, Acis Arzneimittel, Wörwag Pharma, Divis Labs

What are the Application segmentation covered in the Phenprocoumon Market report?

Ans: The Applications covered in the Phenprocoumon Market report are Venous Thrombosis, Thromboembolism, Pulmonary Embolism, Others

What are the Type segmentation covered in the Phenprocoumon Market report?

Ans: The Types covered in the Phenprocoumon Market report are 5 mg, 10 mg, 25 mg, 50 mg

1 Phenprocoumon Market Overview
1.1 Product Definition
1.2 Phenprocoumon by Type
1.2.1 Global Phenprocoumon Market Value Comparison by Type (2024 VS 2031)
1.2.2 5 mg
1.2.3 10 mg
1.2.4 25 mg
1.2.5 50 mg
1.3 Phenprocoumon by Application
1.3.1 Global Phenprocoumon Market Value by Application (2024 VS 2031)
1.3.2 Venous Thrombosis
1.3.3 Thromboembolism
1.3.4 Pulmonary Embolism
1.3.5 Others
1.4 Global Phenprocoumon Market Size Estimates and Forecasts
1.4.1 Global Phenprocoumon Revenue 2020-2031
1.4.2 Global Phenprocoumon Sales 2020-2031
1.4.3 Global Phenprocoumon Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Phenprocoumon Market Competition by Manufacturers
2.1 Global Phenprocoumon Sales Market Share by Manufacturers (2020-2025)
2.2 Global Phenprocoumon Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Phenprocoumon Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Phenprocoumon, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Phenprocoumon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Phenprocoumon, Product Type & Application
2.7 Global Key Manufacturers of Phenprocoumon, Date of Enter into This Industry
2.8 Global Phenprocoumon Market Competitive Situation and Trends
2.8.1 Global Phenprocoumon Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Phenprocoumon Players Market Share by Revenue
2.8.3 Global Phenprocoumon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Phenprocoumon Market Scenario by Region
3.1 Global Phenprocoumon Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Phenprocoumon Sales by Region: 2020-2031
3.2.1 Global Phenprocoumon Sales by Region: 2020-2025
3.2.2 Global Phenprocoumon Sales by Region: 2026-2031
3.3 Global Phenprocoumon Revenue by Region: 2020-2031
3.3.1 Global Phenprocoumon Revenue by Region: 2020-2025
3.3.2 Global Phenprocoumon Revenue by Region: 2026-2031
3.4 North America Phenprocoumon Market Facts & Figures by Country
3.4.1 North America Phenprocoumon Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Phenprocoumon Sales by Country (2020-2031)
3.4.3 North America Phenprocoumon Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Phenprocoumon Market Facts & Figures by Country
3.5.1 Europe Phenprocoumon Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Phenprocoumon Sales by Country (2020-2031)
3.5.3 Europe Phenprocoumon Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Phenprocoumon Market Facts & Figures by Region
3.6.1 Asia Pacific Phenprocoumon Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Phenprocoumon Sales by Region (2020-2031)
3.6.3 Asia Pacific Phenprocoumon Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Phenprocoumon Market Facts & Figures by Country
3.7.1 Latin America Phenprocoumon Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Phenprocoumon Sales by Country (2020-2031)
3.7.3 Latin America Phenprocoumon Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Phenprocoumon Market Facts & Figures by Country
3.8.1 Middle East and Africa Phenprocoumon Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Phenprocoumon Sales by Country (2020-2031)
3.8.3 Middle East and Africa Phenprocoumon Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Phenprocoumon Sales by Type (2020-2031)
4.1.1 Global Phenprocoumon Sales by Type (2020-2025)
4.1.2 Global Phenprocoumon Sales by Type (2026-2031)
4.1.3 Global Phenprocoumon Sales Market Share by Type (2020-2031)
4.2 Global Phenprocoumon Revenue by Type (2020-2031)
4.2.1 Global Phenprocoumon Revenue by Type (2020-2025)
4.2.2 Global Phenprocoumon Revenue by Type (2026-2031)
4.2.3 Global Phenprocoumon Revenue Market Share by Type (2020-2031)
4.3 Global Phenprocoumon Price by Type (2020-2031)
5 Segment by Application
5.1 Global Phenprocoumon Sales by Application (2020-2031)
5.1.1 Global Phenprocoumon Sales by Application (2020-2025)
5.1.2 Global Phenprocoumon Sales by Application (2026-2031)
5.1.3 Global Phenprocoumon Sales Market Share by Application (2020-2031)
5.2 Global Phenprocoumon Revenue by Application (2020-2031)
5.2.1 Global Phenprocoumon Revenue by Application (2020-2025)
5.2.2 Global Phenprocoumon Revenue by Application (2026-2031)
5.2.3 Global Phenprocoumon Revenue Market Share by Application (2020-2031)
5.3 Global Phenprocoumon Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Phenprocoumon Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Phenprocoumon Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Phenprocoumon Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Phenprocoumon Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Phenprocoumon Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Phenprocoumon Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Phenprocoumon Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Roche Phenprocoumon Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Aspen Pharmacare
6.5.1 Aspen Pharmacare Company Information
6.5.2 Aspen Pharmacare Description and Business Overview
6.5.3 Aspen Pharmacare Phenprocoumon Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aspen Pharmacare Phenprocoumon Product Portfolio
6.5.5 Aspen Pharmacare Recent Developments/Updates
6.6 Acis Arzneimittel
6.6.1 Acis Arzneimittel Company Information
6.6.2 Acis Arzneimittel Description and Business Overview
6.6.3 Acis Arzneimittel Phenprocoumon Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Acis Arzneimittel Phenprocoumon Product Portfolio
6.6.5 Acis Arzneimittel Recent Developments/Updates
6.7 Wörwag Pharma
6.7.1 Wörwag Pharma Company Information
6.7.2 Wörwag Pharma Description and Business Overview
6.7.3 Wörwag Pharma Phenprocoumon Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Wörwag Pharma Phenprocoumon Product Portfolio
6.7.5 Wörwag Pharma Recent Developments/Updates
6.8 Divis Labs
6.8.1 Divis Labs Company Information
6.8.2 Divis Labs Description and Business Overview
6.8.3 Divis Labs Phenprocoumon Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Divis Labs Phenprocoumon Product Portfolio
6.8.5 Divis Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Phenprocoumon Industry Chain Analysis
7.2 Phenprocoumon Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Phenprocoumon Production Mode & Process Analysis
7.4 Phenprocoumon Sales and Marketing
7.4.1 Phenprocoumon Sales Channels
7.4.2 Phenprocoumon Distributors
7.5 Phenprocoumon Customer Analysis
8 Phenprocoumon Market Dynamics
8.1 Phenprocoumon Industry Trends
8.2 Phenprocoumon Market Drivers
8.3 Phenprocoumon Market Challenges
8.4 Phenprocoumon Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Mylan NV
TEVA
Roche
Aspen Pharmacare
Acis Arzneimittel
Wörwag Pharma
List of Tables
 Table 1. Global Phenprocoumon Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Phenprocoumon Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Phenprocoumon Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Phenprocoumon Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Phenprocoumon Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Phenprocoumon Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Phenprocoumon Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Phenprocoumon Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Phenprocoumon, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Phenprocoumon, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Phenprocoumon, Product Type & Application
 Table 12. Global Key Manufacturers of Phenprocoumon, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Phenprocoumon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenprocoumon as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Phenprocoumon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Phenprocoumon Sales by Region (2020-2025) & (K Units)
 Table 18. Global Phenprocoumon Sales Market Share by Region (2020-2025)
 Table 19. Global Phenprocoumon Sales by Region (2026-2031) & (K Units)
 Table 20. Global Phenprocoumon Sales Market Share by Region (2026-2031)
 Table 21. Global Phenprocoumon Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Phenprocoumon Revenue Market Share by Region (2020-2025)
 Table 23. Global Phenprocoumon Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Phenprocoumon Revenue Market Share by Region (2026-2031)
 Table 25. North America Phenprocoumon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Phenprocoumon Sales by Country (2020-2025) & (K Units)
 Table 27. North America Phenprocoumon Sales by Country (2026-2031) & (K Units)
 Table 28. North America Phenprocoumon Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Phenprocoumon Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Phenprocoumon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Phenprocoumon Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Phenprocoumon Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Phenprocoumon Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Phenprocoumon Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Phenprocoumon Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Phenprocoumon Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Phenprocoumon Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Phenprocoumon Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Phenprocoumon Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Phenprocoumon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Phenprocoumon Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Phenprocoumon Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Phenprocoumon Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Phenprocoumon Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Phenprocoumon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Phenprocoumon Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Phenprocoumon Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Phenprocoumon Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Phenprocoumon Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Phenprocoumon Sales (K Units) by Type (2020-2025)
 Table 51. Global Phenprocoumon Sales (K Units) by Type (2026-2031)
 Table 52. Global Phenprocoumon Sales Market Share by Type (2020-2025)
 Table 53. Global Phenprocoumon Sales Market Share by Type (2026-2031)
 Table 54. Global Phenprocoumon Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Phenprocoumon Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Phenprocoumon Revenue Market Share by Type (2020-2025)
 Table 57. Global Phenprocoumon Revenue Market Share by Type (2026-2031)
 Table 58. Global Phenprocoumon Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Phenprocoumon Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Phenprocoumon Sales (K Units) by Application (2020-2025)
 Table 61. Global Phenprocoumon Sales (K Units) by Application (2026-2031)
 Table 62. Global Phenprocoumon Sales Market Share by Application (2020-2025)
 Table 63. Global Phenprocoumon Sales Market Share by Application (2026-2031)
 Table 64. Global Phenprocoumon Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Phenprocoumon Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Phenprocoumon Revenue Market Share by Application (2020-2025)
 Table 67. Global Phenprocoumon Revenue Market Share by Application (2026-2031)
 Table 68. Global Phenprocoumon Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Phenprocoumon Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Phenprocoumon Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Mylan Phenprocoumon Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teva Phenprocoumon Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Roche Phenprocoumon Product
 Table 89. Roche Recent Developments/Updates
 Table 90. Aspen Pharmacare Company Information
 Table 91. Aspen Pharmacare Description and Business Overview
 Table 92. Aspen Pharmacare Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Aspen Pharmacare Phenprocoumon Product
 Table 94. Aspen Pharmacare Recent Developments/Updates
 Table 95. Acis Arzneimittel Company Information
 Table 96. Acis Arzneimittel Description and Business Overview
 Table 97. Acis Arzneimittel Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Acis Arzneimittel Phenprocoumon Product
 Table 99. Acis Arzneimittel Recent Developments/Updates
 Table 100. Wörwag Pharma Company Information
 Table 101. Wörwag Pharma Description and Business Overview
 Table 102. Wörwag Pharma Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Wörwag Pharma Phenprocoumon Product
 Table 104. Wörwag Pharma Recent Developments/Updates
 Table 105. Divis Labs Company Information
 Table 106. Divis Labs Description and Business Overview
 Table 107. Divis Labs Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Divis Labs Phenprocoumon Product
 Table 109. Divis Labs Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Phenprocoumon Distributors List
 Table 113. Phenprocoumon Customers List
 Table 114. Phenprocoumon Market Trends
 Table 115. Phenprocoumon Market Drivers
 Table 116. Phenprocoumon Market Challenges
 Table 117. Phenprocoumon Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Phenprocoumon
 Figure 2. Global Phenprocoumon Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Phenprocoumon Market Share by Type: 2024 & 2031
 Figure 4. 5 mg Product Picture
 Figure 5. 10 mg Product Picture
 Figure 6. 25 mg Product Picture
 Figure 7. 50 mg Product Picture
 Figure 8. Global Phenprocoumon Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Phenprocoumon Market Share by Application: 2024 & 2031
 Figure 10. Venous Thrombosis
 Figure 11. Thromboembolism
 Figure 12. Pulmonary Embolism
 Figure 13. Others
 Figure 14. Global Phenprocoumon Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Phenprocoumon Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Phenprocoumon Sales (2020-2031) & (K Units)
 Figure 17. Global Phenprocoumon Average Price (US$/Unit) & (2020-2031)
 Figure 18. Phenprocoumon Report Years Considered
 Figure 19. Phenprocoumon Sales Share by Manufacturers in 2024
 Figure 20. Global Phenprocoumon Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Phenprocoumon Players: Market Share by Revenue in Phenprocoumon in 2024
 Figure 22. Phenprocoumon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Phenprocoumon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Phenprocoumon Sales Market Share by Country (2020-2031)
 Figure 25. North America Phenprocoumon Revenue Market Share by Country (2020-2031)
 Figure 26. United States Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Phenprocoumon Sales Market Share by Country (2020-2031)
 Figure 29. Europe Phenprocoumon Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Phenprocoumon Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Phenprocoumon Revenue Market Share by Region (2020-2031)
 Figure 37. China Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Phenprocoumon Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Phenprocoumon Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Phenprocoumon Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Phenprocoumon Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Phenprocoumon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Phenprocoumon by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Phenprocoumon by Type (2020-2031)
 Figure 58. Global Phenprocoumon Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Phenprocoumon by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Phenprocoumon by Application (2020-2031)
 Figure 61. Global Phenprocoumon Price (US$/Unit) by Application (2020-2031)
 Figure 62. Phenprocoumon Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Acenocoumarol Market Research Report 2024
Global Nicoumalone Market Research Report 2024
Global Nadroparin Calcium Market Research Report 2024
Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2024
Global Oral Factor Xa Inhibitors Market Research Report 2024
Global Rivaroxaban Drugs Market Research Report 2024
Global Rivaroxaban Market Insights Forecast to 2030
Global Factor Xa Inhibitors Market Research Report 2024
Global Fraxiparine Market Research Report 2024
Carboprost Tromethamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global LMWH Products Market Insights Forecast to 2030
Global Anticoagulant Drugs Market Insights Forecast to 2030
Global Ofatumumab Market Research Report 2024
Nadolol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Anticoagulants Market Research Report 2024
Global Anticoagulant Medicines Market Research Report 2025
4 Factor Pro thrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Coagulant Rodenticides Market Research Report 2025
Global Injectable Anticoagulants Market Research Report 2025
Global Fondaparinux Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions